Original Research
Published on 05 Aug 2022
Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistance
in Hematologic Malignancies
- 4,443 views
- 3 citations
Original Research
Published on 05 Aug 2022
in Hematologic Malignancies
Original Research
Published on 11 Aug 2022
in Genitourinary Oncology
Original Research
Published on 26 Mar 2021
in Molecular and Cellular Oncology
Review
Published on 24 Mar 2023
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 13 Aug 2019
in Computational Genomics
Original Research
Published on 22 Jan 2019
in Cancer Immunity and Immunotherapy
Protocols
Published on 19 Feb 2018
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 03 Jul 2020
in Pathology
Original Research
Published on 21 Sep 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 07 Mar 2023
in Precision Medicine
Perspective
Published on 19 Jan 2017
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 10 Jul 2020
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 23 Jun 2020
in Molecular and Cellular Oncology
Original Research
Published on 22 Jan 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 03 Jan 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 13 Jul 2021
in Gastrointestinal Cancers